---
title: "Takeda Pharmaceutical Company (TAK.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TAK.US/norm.md"
symbol: "TAK.US"
name: "Takeda Pharmaceutical Company"
parent: "https://longbridge.com/en/quote/TAK.US.md"
datetime: "2026-03-07T07:17:05.893Z"
locales:
  - [en](https://longbridge.com/en/quote/TAK.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TAK.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TAK.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TAK.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TAK.US/norm.md)


# Takeda Pharmaceutical Company (TAK.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2063 | -0.0252 | 0.2702 | -0.2178 | 0.0479 |
| ROE | 5.61% | -0.67% | 7.20% | -5.75% | 1.33% |
| Revenue | 7.62B | 7.49B | 7.65B | 7.03B | 7.30B |
| Net income | 662.38M | -79.40M | 858.28M | -688.83M | 151.69M |
| Operating income | 826.07M | 1.14B | 1.29B | 821.46M | 77.49M |
| Gross margin | 66.34% | 65.85% | 65.24% | 64.56% | 63.56% |
| Net margin | 8.70% | -1.06% | 11.23% | -9.79% | 2.08% |
| Profit quality | 34.63% | 44.99% | 86.74% | 55.37% | 3.17% |

## Balance Sheet (USD)

| Indicator | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 98.48B | 97.36B | 96.74B | 95.14B | 96.33B |
| Leverage | 2.02 | 2.03 | 2.04 | 2.05 | 2.04 |
| BVPS | 15.46 | 15.19 | 15.18 | 14.71 | 14.92 |
| Turnover | 0.2926 | 0.3042 | 0.2964 | 0.3121 | 0.3122 |
| Cash & STI | 4.19B | 4.59B | 2.42B | 2.57B | 3.15B |
| Inv & Rec | 8.99B | 8.74B | 8.57B | 8.13B | 7.95B |
| LT assets | 13.32B | 13.35B | 13.51B | 13.14B | 12.87B |
| Net debt | 30.47B | 30.34B | 32.41B | 31.41B | 31.48B |

## Cash Flow Statement (USD)

| Indicator | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 2.39B | 2.54B | 1.49B | 1.48B | 2.45B |
| Investing CF | -1.47B | -323.84M | -229.30M | -131.42M | -736.84M |
| Financing CF | -1.23B | -80.61M | -1.48B | -2.02B | -4.18B |
| Free CF | 181.15M | 1.54B | 816.25M | 1.65B | 1.85B |
| OCF coverage | 186.11% | 106.59% | 57.18% | 76.73% | 54.71% |
| Repaid & issued | 0.0000 | 2.30B | 1.27B | 183.57M | 255.06M |
| CapEx | -266.08M | -269.76M | -330.99M | -325.82M | -287.50M |

## Distribution Plan

**Dividend Yield**: 2.95

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.33901USD | 2025-03-31 | 2025-03-31 | 2025-07-07 |
| Cash Dividend: 
0.283471USD | 2024-09-30 | 2024-09-30 | 2024-12-12 |
| Cash Dividend: 
0.252992USD | 2024-03-28 | 2024-03-27 | 2024-07-08 |